Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$1.5 - $4.82 $41,250 - $132,550
27,500 New
27,500 $69,000
Q2 2022

Aug 09, 2022

SELL
$3.15 - $7.94 $46,790 - $117,940
-14,854 Reduced 36.23%
26,146 $82,000
Q1 2022

May 12, 2022

BUY
$6.18 - $14.44 $253,380 - $592,040
41,000 New
41,000 $253,000

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $80.7M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.